HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Ogawa Selected Research

4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acid

12/2014[Novel treatment for prostate cancer targeting prostaglandins].
9/2014An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
2/2010Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Ogawa Research Topics

Disease

147Neoplasms (Cancer)
02/2022 - 01/2002
132Prostatic Neoplasms (Prostate Cancer)
07/2022 - 01/2002
49Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 04/2002
45Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2002
38Neoplasm Metastasis (Metastasis)
01/2022 - 11/2002
28Carcinoma (Carcinomatosis)
01/2022 - 01/2002
13Disease Progression
01/2022 - 11/2002
11Carcinogenesis
01/2020 - 08/2004
9Infections
01/2018 - 06/2004
8Inflammation (Inflammations)
05/2022 - 01/2002
8Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2021 - 02/2004
7Lymphatic Metastasis
01/2022 - 01/2004
7Adenocarcinoma
07/2021 - 11/2013
7Chronic Kidney Failure (Chronic Renal Failure)
04/2021 - 11/2003
7Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2020 - 01/2002
6Cystitis
05/2022 - 12/2003
6Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2016
6Testicular Neoplasms (Testicular Cancer)
10/2021 - 01/2004
6Alzheimer Disease (Alzheimer's Disease)
01/2019 - 09/2002
6Hypertension (High Blood Pressure)
12/2016 - 10/2003
6Transitional Cell Carcinoma
06/2008 - 02/2002
5Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 12/2003
5Breast Neoplasms (Breast Cancer)
01/2019 - 02/2002
5Seminoma
07/2017 - 12/2010
4Hypoxia (Hypoxemia)
01/2022 - 02/2006
4Hemorrhage
01/2022 - 06/2009
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 12/2004
4Hepatitis
12/2020 - 11/2003
4Brain Death (Brain Dead)
11/2020 - 11/2003
4Margins of Excision
03/2020 - 06/2004
4Fibrosis (Cirrhosis)
01/2020 - 12/2003
4Hepatocellular Carcinoma (Hepatoma)
10/2019 - 11/2002
4Carcinoma in Situ
12/2017 - 05/2004

Drug/Important Bio-Agent (IBA)

32AndrogensIBA
01/2022 - 11/2002
26Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 01/2002
26Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2002
23Biomarkers (Surrogate Marker)IBA
10/2021 - 10/2003
20Androgen Receptors (Androgen Receptor)IBA
01/2022 - 04/2003
18Cisplatin (Platino)FDA LinkGeneric
10/2021 - 06/2002
17Hormones (Hormone)IBA
05/2019 - 11/2002
11Docetaxel (Taxotere)FDA Link
01/2022 - 01/2011
11Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 10/2005
11Messenger RNA (mRNA)IBA
04/2015 - 04/2002
10Biological ProductsIBA
05/2020 - 04/2003
9Pharmaceutical PreparationsIBA
09/2021 - 09/2002
8pembrolizumabIBA
02/2022 - 01/2021
8DNA (Deoxyribonucleic Acid)IBA
10/2019 - 03/2003
6Hemoglobins (Hemoglobin)IBA
01/2022 - 05/2005
6GemcitabineFDA Link
12/2019 - 02/2006
6Carboplatin (JM8)FDA LinkGeneric
10/2019 - 10/2005
5TOR Serine-Threonine KinasesIBA
05/2022 - 12/2006
5abirateroneIBA
01/2022 - 01/2017
5NivolumabIBA
05/2021 - 01/2016
5Immune Checkpoint InhibitorsIBA
02/2021 - 01/2020
5EnzymesIBA
01/2021 - 01/2002
5C-Reactive ProteinIBA
10/2019 - 10/2004
5Sunitinib (Sutent)FDA Link
05/2019 - 01/2012
5Codon (Codons)IBA
01/2019 - 02/2002
5Peptides (Polypeptides)IBA
01/2019 - 09/2010
5AldosteroneIBA
12/2018 - 10/2003
5enzalutamideIBA
09/2018 - 01/2016
5SteroidsIBA
01/2018 - 05/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2016 - 05/2002
5CreatinineIBA
10/2016 - 06/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 11/2002
4Connexin 43 (Connexin43)IBA
05/2022 - 09/2006
4PlatinumIBA
12/2021 - 01/2018
4Cell-Free Nucleic AcidsIBA
11/2021 - 10/2019
4Phospholipids (Phosphatides)FDA LinkGeneric
10/2021 - 12/2015
4Capsules (Microcapsules)IBA
04/2021 - 12/2003
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 08/2014
4Transcription Factors (Transcription Factor)IBA
01/2020 - 02/2006
4InterferonsIBA
07/2016 - 08/2007
4Insulin (Novolin)FDA Link
01/2016 - 07/2003
4CytokinesIBA
01/2016 - 10/2007
4Tumor Biomarkers (Tumor Markers)IBA
04/2015 - 11/2002
4Interferon-alpha (Interferon Alfa)IBA
06/2010 - 07/2007
4Phosphotransferases (Kinase)IBA
06/2010 - 10/2005
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2008 - 11/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2022 - 01/2014
3LigandsIBA
01/2022 - 05/2002

Therapy/Procedure

77Therapeutics
01/2022 - 04/2002
41Drug Therapy (Chemotherapy)
02/2022 - 01/2002
39Castration
01/2022 - 02/2010
28Radiotherapy
07/2022 - 10/2006
24Cystectomy
01/2022 - 01/2004
21Prostatectomy (Retropubic Prostatectomy)
04/2020 - 09/2006
19Nephrectomy
01/2022 - 07/2003
9Lymph Node Excision (Lymph Node Dissection)
01/2022 - 02/2004
9Orchiectomy (Orchidectomy)
01/2021 - 03/2002
8Immunotherapy
02/2022 - 07/2007
8Kidney Transplantation
04/2021 - 06/2002
8Neoadjuvant Therapy
01/2021 - 01/2006
8Nephroureterectomy
12/2019 - 01/2002
5Transplantation
11/2019 - 06/2002
4Aftercare (After-Treatment)
10/2021 - 11/2002
4Liver Transplantation
11/2020 - 11/2003
4Urinary Diversion (Ileal Conduit)
06/2020 - 06/2009
4Operative Time
03/2020 - 06/2004
4Combination Drug Therapy (Combination Chemotherapy)
08/2014 - 02/2006